Available nationwide
Online GLP-1 weight loss in all 50 states.
One price, one process and one care team, wherever you live. Pick your state to see how Rovymi works there.
Is Rovymi available in my state?
Yes. Rovymi provides clinician-guided GLP-1 weight-loss care online in all 50 states. A U.S.-licensed clinician who can treat patients in your state reviews your questionnaire; some states also require a short video visit. If treatment is prescribed, compounded semaglutide (from $129/mo) or tirzepatide ships free to your door.
Popular states
Every state we serve
Rovymi serves every one of these states. Pick yours for a local guide with walking spots, food and weather tips, and answers for your state.
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Availability questions
Good to know.
No. Plans cost the same in every state and at every dose, and the price includes your clinician review, medication, supplies, shipping and unlimited messaging.
Most people only complete the online questionnaire. Some states, or some health histories, call for a short video visit; your clinician will let you know if you need one.
Usually, yes. Update your address in your patient portal before your next shipment, and your care team will confirm that a clinician who can treat patients in your new state reviews your care.
Yes. Medication ships free, in discreet packaging with tracking, to addresses across every state we serve.
Important Safety Information
Warning: possible thyroid tumors, including cancer. In studies in rodents, tirzepatide and semaglutide caused thyroid C-cell tumors. It is not known whether they cause these tumors in people. Do not use GLP-1 medication if you or a family member has ever had medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician about a lump or swelling in your neck, trouble swallowing, hoarseness or shortness of breath.
Do not use if you are pregnant, planning to become pregnant or breastfeeding, or if you have had a serious allergic reaction to tirzepatide, semaglutide or any ingredient.
Serious side effects can include pancreatitis, gallbladder problems, low blood sugar, kidney problems, serious allergic reactions, vision changes in people with diabetes, and mood changes. Common side effects include nausea, diarrhea, vomiting and constipation. Compounded medications are not FDA-approved. Read the full Important Safety Information.
Ready when you are.
Answer a few questions online. A licensed clinician reviews them and, if it's right for you, your treatment ships to your door.
See if you qualify